BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 24258565)

  • 41. Clinical practice. The solitary pulmonary nodule.
    Ost D; Fein AM; Feinsilver SH
    N Engl J Med; 2003 Jun; 348(25):2535-42. PubMed ID: 12815140
    [No Abstract]   [Full Text] [Related]  

  • 42. Dynamic contrast-enhanced computed tomography for the diagnosis of solitary pulmonary nodules: a systematic review and meta-analysis.
    Weir-McCall JR; Joyce S; Clegg A; MacKay JW; Baxter G; Dendl LM; Rintoul RC; Qureshi NR; Miles K; Gilbert FJ
    Eur Radiol; 2020 Jun; 30(6):3310-3323. PubMed ID: 32060716
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Management of Pulmonary Nodules by Community Pulmonologists: A Multicenter Observational Study.
    Tanner NT; Aggarwal J; Gould MK; Kearney P; Diette G; Vachani A; Fang KC; Silvestri GA
    Chest; 2015 Dec; 148(6):1405-1414. PubMed ID: 26087071
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pulmonary nodule: a comprehensive review and update.
    Asija A; Manickam R; Aronow WS; Chandy D
    Hosp Pract (1995); 2014 Aug; 42(3):7-16. PubMed ID: 25255402
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules.
    Bryant AS; Cerfolio RJ
    Ann Thorac Surg; 2006 Sep; 82(3):1016-20. PubMed ID: 16928527
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnostic accuracy of contrast-enhanced computed tomography and positron emission tomography with 18-FDG in identifying malignant solitary pulmonary nodules.
    Dabrowska M; Krenke R; Korczynski P; Maskey-Warzechowska M; Zukowska M; Kunikowska J; Orłowski T; Chazan R
    Medicine (Baltimore); 2015 Apr; 94(15):e666. PubMed ID: 25881842
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The solitary pulmonary nodule. Decision analysis.
    Kunstaetter R; Wolkove N; Kreisman H; Cohen C; Frank H
    Med Decis Making; 1985; 5(1):61-75. PubMed ID: 3840863
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The solitary pulmonary nodule.
    Tan BB; Flaherty KR; Kazerooni EA; Iannettoni MD;
    Chest; 2003 Jan; 123(1 Suppl):89S-96S. PubMed ID: 12527568
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A clinical model to estimate the pretest probability of lung cancer in patients with solitary pulmonary nodules.
    Gould MK; Ananth L; Barnett PG;
    Chest; 2007 Feb; 131(2):383-8. PubMed ID: 17296637
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Physician Assessment of Pretest Probability of Malignancy and Adherence With Guidelines for Pulmonary Nodule Evaluation.
    Tanner NT; Porter A; Gould MK; Li XJ; Vachani A; Silvestri GA
    Chest; 2017 Aug; 152(2):263-270. PubMed ID: 28115167
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Management of solitary pulmonary nodules.
    Lillington GA
    Dis Mon; 1991 May; 37(5):271-318. PubMed ID: 2019220
    [TBL] [Abstract][Full Text] [Related]  

  • 52. When is a biopsy-proven diagnosis necessary before stereotactic ablative radiotherapy for lung cancer?: A decision analysis.
    Louie AV; Senan S; Patel P; Ferket BS; Lagerwaard FJ; Rodrigues GB; Salama JK; Kelsey C; Palma DA; Hunink MG
    Chest; 2014 Oct; 146(4):1021-1028. PubMed ID: 24853550
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intrapulmonary solitary fibrous tumor.
    Kawaguchi K; Taniguchi T; Usami N; Yokoi K
    Gen Thorac Cardiovasc Surg; 2011 Jan; 59(1):61-4. PubMed ID: 21225405
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diffusion-weighted magnetic resonance for pulmonary nodules: 1.5 vs. 3 Tesla.
    Ohba Y; Nomori H; Mori T; Shiraishi K; Namimoto T; Katahira K
    Asian Cardiovasc Thorac Ann; 2011 Apr; 19(2):108-14. PubMed ID: 21471253
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis models to assess cost effectiveness of the four strategies for the work-up of solitary pulmonary nodules.
    Tsushima Y; Endo K
    Med Sci Monit; 2004 May; 10(5):MT65-72. PubMed ID: 15114278
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preliminary study on the correlation between grading and histology of solitary pulmonary nodules and contrast enhancement and [18F]fluorodeoxyglucose standardised uptake value after evaluation by dynamic multiphase CT and PET/CT.
    Cappabianca S; Porto A; Petrillo M; Greco B; Reginelli A; Ronza F; Setola F; Rossi G; Di Matteo A; Muto R; De Rimini ML; Piccolo S; Catalano M; Muto P; De Rosa N; Barra E; De Rosa I; Antinolfi F; Antinolfi G; Caputi M; Brunese L; Grassi R; Rotondo A
    J Clin Pathol; 2011 Feb; 64(2):114-9. PubMed ID: 21169276
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical-radiological predictive model in differential diagnosis of small (≤ 20 mm) solitary pulmonary nodules.
    Zhao HC; Xu QS; Shi YB; Ma XJ
    BMC Pulm Med; 2021 Sep; 21(1):281. PubMed ID: 34482833
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Solitary pulmonary nodules: detection, characterization, and guidance for further diagnostic workup and treatment].
    Jeong YJ; Yi CA; Lee KS
    Radiologia; 2008; 50(3):183-95. PubMed ID: 18471382
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of PET/CT in the characterization of solid or partly solid solitary pulmonary nodules.
    Jeong SY; Lee KS; Shin KM; Bae YA; Kim BT; Choe BK; Kim TS; Chung MJ
    Lung Cancer; 2008 Aug; 61(2):186-94. PubMed ID: 18280613
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnostic performance of PET/CT in differentiation of malignant and benign non-solid solitary pulmonary nodules.
    Tsushima Y; Tateishi U; Uno H; Takeuchi M; Terauchi T; Goya T; Kim EE
    Ann Nucl Med; 2008 Aug; 22(7):571-7. PubMed ID: 18756359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.